• Guest - w'd love to know what you think about the forum! Take the 2026 Survey »

Recent Content by Bill_St

  1. B

    Glucose monitor - recommendations please

    Certainly try the free samples from both Dexcom and Libre as mentioned above. Only for two weeks each but they give much more information on change in levels and help to see when to use test strips if needed. They may not last the full two weeks for a new user but that can easily be an...
  2. B

    Medication

    Someone has misread and misinterpreted the new guidance just released for healthcare professionals. Much of it is actually very good and is something we have been fighting for, for months. Link above ….
  3. B

    Medication

    It is not NICE guidelines for you - it is the guidelines for GPs prescribing. The key words are OFFER….DISCUSS …. And SHARED DECISIONS Take a copy and spread the word. It is now our need to help educate those who misread and misinterpret guidance. ;)...
  4. B

    Metformin, good or bad?

    I agree with the recommendation for the David Mendoza blog above. The direct link to Metformin is https://www.mendosa.com/blog/?p=3884 I find that the long acting version is most effective, 500mg twice a day - but that is for me - remember diabetes is different for all of us - we are all different.
  5. B

    Libre Sensor 2 lasts one week or less over and over again

    The vital thing for some people is to ensure the filament is stable. It is wide variation of readings that causes the failure notice. Any instability can cause this. Some find that pressing firmly for 15-20 seconds during the installation allows the adhesive to bond more firmly. Also during...
  6. B

    Libre 2

    Does the trace line go into the red or is it just the spot readings and alarm? The latter can vary quite a lot with a new sensor but it may settle after two or three days. The average trace line is much more accurate.
  7. B

    Dapagliflozin 10mg Side effects

    Important to drink plenty of water. How is your blood pressure?
  8. B

    Fixating on insulin is starting to annoy me!

    At least some are beginning to recognise the lack of knowledge about D and are attempting to get hospitals to improve - they are recognising the safety issues, both in-patient and when sent home. But more still needs to be done both in-patient hospital and in general practice...
  9. B

    Low glucose or not?

    Sensor,ends in 15 days. So a brand new sensor. Sensors are known to be inaccurate in the first day or so. This can also be seen on the trace including a gap. Wildly changing is also a sign of inaccuracy. Certainly report to Abbott who may offer a free replacement but they can withhold on new...
  10. B

    Latest research into Terzepatide (Mounjaro) for T1 in USA

    Life-changing medications like Ozempic and Mounjaro are only approved right now for type 2 diabetes, but a growing body of evidence highlights the benefits of GLP-1s for people with type 1 diabetes. Now, researchers are analyzing the data to see how GLP-1 drugs affect the risk of heart, kidney...
  11. B

    No need to repeat what Hospital already does

    I live 6mths a year in Spain and up to 6 mths in UK. So I have two GPs. Self funded in Spain and NHS in UK. I also have access to specialists in both. Some prescriptions in Spain are cheaper than through NHS (going by amount paid to pharmacy). So I balance sources and availability- much quicker...
  12. B

    Insulin and self medication in hospital

    Section 3.1 HSSIB has identified local-level learning for NHS trusts Do you have a policy that supports patients to safely self-manage their diabetes and support self-administration of insulin? Is your policy clear, available, and does it enable clinicians to support safe self-management and...
  13. B

    Insulin and self medication in hospital

    I would hope everyone has a “Go Bag” prepared in case of a hospital admission. Perhaps worth having two preprepared letters in your Go bag ready to give one to any admission team, giving the reference to the above and asking if the hospital conforms to the recommendations, particularly...
  14. B

    Weight Loss and Diabetes

    They were excluded from the original trial data but were then selected in this appraisal.
  15. B

    Weight Loss and Diabetes

    Section 3.1 & 3.2 https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.70660 It seems they were excluded. Quite large numbers seemed to change to tirzepatide (Mounjaro). It would be interesting to see subsequent data on these. Cost and insurance were the main reasons for change...
Back
Top